NCT06037486
System Accuracy of BGM GL60
Evaluierung Der Systemgenauigkeit Des Blutglucosemonitoring Systems GL60 gemäß DIN EN ISO 15197:2015
Institut fur Diabetes Karlsburg GmbH·ClinicalTrials.gov·diagnostic testCompleted
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Diabetes Mellitus
- Drug/Device/Intervention
- Glucometer Test
- Study type
- Interventional
- Intervention type
- diagnostic test
Sponsor & location
- Primary sponsor
- Institut fur Diabetes Karlsburg GmbH
- Location
- Karlsburg, Germany
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 17, 2022
- End date
- Nov 15, 2022
- Enrollment
- 101 participants
Primary outcome
Analysis of system accuracy based on DIN EN ISO 15197
Summary
This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO
 15197
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06037486
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06037486 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 101 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.